lidocaine has been researched along with thromboxane a2 in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chignard, M; Vargaftig, BB | 1 |
Berntsen, RF; Olsen, H; Sager, G; Simonsen, T | 1 |
Cudd, TA | 1 |
Durieux, M; Erera, JS; Gear, AR; Honemann, CW; Lo, B; Polanowska-Grabowska, R | 1 |
Durieux, ME; Gear, AR; Hollmann, MW; Hönemann, CW; Kohrs, R; Lo, B; Polanowska-Grabowska, RK | 1 |
Durieux, ME; Hahnenkamp, K; Hollmann, MW; Hönemann, CW; Podranski, T; Strumper, D | 1 |
Casutt, M; Dusch, M; Haberthür, C; Konrad, CJ; Rukwied, R; Schley, MT; Schmeck, J; Schmelz, M; Schüpfer, GK | 1 |
7 other study(ies) available for lidocaine and thromboxane a2
Article | Year |
---|---|
Why do some beta adrenergic agonists inhibit generation of thromboxane A2 in incubates of platelets with arachidonic acid?
Topics: Adenosine Diphosphate; Adrenergic beta-Agonists; Albuterol; Animals; Arachidonic Acids; Blood Platelets; Dogs; In Vitro Techniques; Isoproterenol; Lidocaine; Platelet Aggregation; Thromboxane A2; Thromboxanes | 1978 |
Therapeutic lidocaine concentrations have no effect on blood platelet function and plasma catecholamine levels.
Topics: Adult; beta-Thromboglobulin; Blood Platelets; Catecholamines; Female; Humans; Lidocaine; Male; Middle Aged; Platelet Aggregation; Thromboxane A2 | 1992 |
Vagal blockade does not prevent adrenocorticotropin, cortisol, and cardiopulmonary responses to thromboxane A2.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenocorticotropic Hormone; Afferent Pathways; Animals; Blood Pressure; Carbon Dioxide; Cardiovascular System; Female; Heart Rate; Hematocrit; Hydrocortisone; Infusions, Intravenous; Lidocaine; Nerve Block; Oxygen; Phenylephrine; Pituitary-Adrenal System; Sheep; Thromboxane A2; Vagus Nerve | 1998 |
Local anesthetic effects on TXA2 receptor mediated platelet aggregation using quenched flow aggregometry.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Amides; Anesthetics, Local; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Bupivacaine; Fatty Acids, Unsaturated; Humans; Hydrazines; In Vitro Techniques; Lidocaine; Platelet Aggregation; Receptors, Thromboxane; Ropivacaine; Signal Transduction; Thromboxane A2 | 1999 |
Local anesthetic actions on thromboxane-induced platelet aggregation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Amides; Anesthetics, Local; Bupivacaine; Humans; Lidocaine; Platelet Aggregation; Ropivacaine; Thromboxane A2 | 2001 |
Local anesthetics inhibit thromboxane A2 signaling in Xenopus oocytes and human k562 cells.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Anesthetics, Local; Animals; Calcium; Female; Humans; K562 Cells; Lidocaine; Oocytes; Signal Transduction; Thromboxane A2; Xenopus | 2004 |
Long-acting local anesthetics attenuate FMLP-induced acute lung injury in rats.
Topics: Acute Lung Injury; Amides; Anesthesia, Local; Animals; Anti-Inflammatory Agents; Bupivacaine; Endothelin-1; Female; Granulocytes; Lidocaine; Male; Mepivacaine; N-Formylmethionine Leucyl-Phenylalanine; Rats; Rats, Sprague-Dawley; Ropivacaine; Thromboxane A2; Vasoconstrictor Agents | 2009 |